The Beauty Health Company (NASDAQ:SKIN) Director Desiree Gruber Sells 14,663 Shares

The Beauty Health Company (NASDAQ:SKIN) Director Desiree Gruber sold 14,663 shares of the company’s stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $1.50, for a total value of $21,994.50. Following the completion of the transaction, the director now owns 119,514 shares in the company, valued at $179,271. This represents a 10.93 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Beauty Health Trading Up 1.1 %

Shares of Beauty Health stock traded up $0.02 during trading on Friday, reaching $1.41. The company’s stock had a trading volume of 133,309 shares, compared to its average volume of 1,840,430. The Beauty Health Company has a 12-month low of $0.91 and a 12-month high of $5.17. The company has a quick ratio of 5.57, a current ratio of 6.56 and a debt-to-equity ratio of 9.23. The business has a 50 day moving average price of $1.58 and a 200-day moving average price of $1.83.

Analyst Ratings Changes

Several brokerages recently issued reports on SKIN. Canaccord Genuity Group boosted their price objective on shares of Beauty Health from $1.25 to $1.75 and gave the company a “hold” rating in a report on Wednesday, November 13th. Stifel Nicolaus decreased their price target on shares of Beauty Health from $4.00 to $2.00 and set a “hold” rating for the company in a research report on Friday, July 26th. Finally, Piper Sandler restated an “underweight” rating and set a $1.00 target price (down from $1.50) on shares of Beauty Health in a research note on Friday, August 9th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $2.55.

Institutional Trading of Beauty Health

A number of institutional investors have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. acquired a new stake in shares of Beauty Health during the 1st quarter valued at approximately $279,000. Price T Rowe Associates Inc. MD grew its stake in Beauty Health by 8.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 75,281 shares of the company’s stock valued at $335,000 after acquiring an additional 5,934 shares during the last quarter. Bayesian Capital Management LP acquired a new position in Beauty Health during the first quarter worth about $521,000. Jacobs Levy Equity Management Inc. purchased a new stake in shares of Beauty Health in the first quarter valued at about $4,297,000. Finally, 180 Wealth Advisors LLC raised its position in shares of Beauty Health by 25.3% during the 2nd quarter. 180 Wealth Advisors LLC now owns 101,855 shares of the company’s stock worth $187,000 after purchasing an additional 20,570 shares during the last quarter. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.